相关实验视频
Updated: Jul 16, 2025

08:04
Murine Fetal Echocardiography
Published on: February 15, 2013
17.4K
产前诊断的腹腔间静脉动脉瘤与相关的腹腔功能障碍
Julia E Behrend1, Amy S Lay2, Nicholas K Brown3
1Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. julia.e.behrend@gmail.com.
Pediatric cardiology
|September 21, 2023
概括
先天性腹腔间隔膜动脉瘤 (IVSA) 是一种罕见的心脏病. 这项研究突出了一个罕见的胎儿IVSA病例,与心室功能障碍和心周溢出有关.
科学领域:
- 心脏病学 心脏病学
- 胎儿医学 胎儿医学
- 儿童心脏病学 儿童心脏病学
背景情况:
- 肌肉隔膜的先天性肠隔膜动脉瘤 (IVSA) 是一种罕见的心脏形.
- IVSA可能与其他先天性心脏缺陷,心律失常和染色体异常有关.
- 关于IVSA在子宫表现的报道有限,特别是与心室功能障碍和非收缩有关.
研究的目的:
- 描述一个罕见的胎儿腹腔间隔膜动脉瘤病例.
- 要突出胎儿IVSA与心室功能障碍和心周溢血的关联.
- 为有限的关于IVSA产前诊断和影响的文献做出贡献.
主要方法:
- 一个胎儿的病例报告,诊断出患有腹腔间隔膜动脉瘤.
- 产前成像 (心声) 被用于诊断.
- 审查了临床数据,包括相关的心脏和心脏外发现.
主要成果:
- 在胎儿身上发现了一种罕见的先天性腹腔间隔膜动脉瘤病例.
- 胎儿的IVSA与显著的心室功能障碍有关.
- 在与胎儿IVSA和心室功能障碍相关的情况下,还注意到心周溢血.
结论:
- 胎儿腹腔间隔膜动脉瘤可以呈现心室功能障碍和心周溢出.
- 产前诊断IVSA对于适当的管理和咨询至关重要.
- 需要进一步的研究来了解胎儿IVSA的长期结果和管理策略.
相关概念视频
Mitral Stenosis I: Introduction
15
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Mitral Stenosis II: Clinical features and Diagnostic Tests
22
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
22
Aneurysm II: Clinical Manifestations and Diagnostic Studies
10
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
10
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11

